[Molecular mechanisms of the pathogenesis of epileptic activity (II)].
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000502:physiology; D006152:Cyclic GMP / Q000502:physiology; D004597:Electroshock; D004827:Epilepsy / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000502:physiology; D011188:Potassium / Q000378:metabolism; D012640:Seizures / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D000927:Anticonvulsants; D007473:Ion Channels; D012964:Sodium; D000242:Cyclic AMP; D000254:Sodium-Potassium-Exchanging ATPase; D006152:Cyclic GMP; D011188:Potassium
Molekuliarnye mekhanizmy patogeneza épilepticheskoĭ aktivnosti (soobshchenie II).